T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DBD
1726
DELISTED
Diebold Nixdorf Incorporated
DBD
| $923K | ﹤0.01% |
30,990
| – | – |
|
1727
WaFd
WAFD
$2.81B
| $922K | ﹤0.01% |
40,510
| – | – |
|
|
INFN
1728
DELISTED
Infinera Corporation Common Stock
INFN
| $917K | ﹤0.01% |
46,900
-8,800
| -16% | -$192K |
|
1729
Brixmor Property Group
BRX
$9.21B
| $916K | ﹤0.01% |
39,000
+5,700
| +17% | +$136K |
|
1730
ITT
ITT
$19.4B
| $916K | ﹤0.01% |
27,400
| – | – |
|
1731
Bank OZK
OZK
$5.7B
| $906K | ﹤0.01% |
20,700
+1,700
| +9% | +$74.1K |
|
1732
Bank of Hawaii
BOH
$3.15B
| $899K | ﹤0.01% |
14,166
+4,200
| +42% | +$273K |
|
|
GNC
1733
DELISTED
GNC Holdings, Inc.
GNC
| $891K | ﹤0.01% |
22,034
-1,460
| -6% | -$66.6K |
|
1734
The GEO Group
GEO
$4B
| $887K | ﹤0.01% |
44,726
| – | – |
|
1735
Silgan Holdings
SLGN
$4.46B
| $886K | ﹤0.01% |
34,040
| – | – |
|
|
WNR
1736
DELISTED
Western Refining Inc
WNR
| $882K | ﹤0.01% |
20,000
-1,600
| -7% | -$71.8K |
|
|
VISN
1737
Vistance Networks Inc
VISN
$2.62B
| $880K | ﹤0.01% |
29,300
+7,100
| +32% | +$220K |
|
1738
PENN Entertainment
PENN
$2.53B
| $880K | ﹤0.01% |
52,454
+22,440
| +75% | +$410K |
|
|
VR
1739
DELISTED
Validus Hold Ltd
VR
| $879K | ﹤0.01% |
19,500
| – | – |
|
1740
Watsco Inc
WSO
$12.9B
| $877K | ﹤0.01% |
7,400
+1,000
| +16% | +$125K |
|
|
MDP
1741
DELISTED
Meredith Corporation
MDP
| $873K | ﹤0.01% |
20,500
+1,500
| +8% | +$71.4K |
|
|
PETX
1742
DELISTED
Aratana Therapeutics, Inc.
PETX
| $867K | ﹤0.01% |
+102,501
| New | +$1.73M |
|
|
FMER
1743
DELISTED
FIRSTMERIT CORP
FMER
| $864K | ﹤0.01% |
48,876
| – | – |
|
|
CY
1744
DELISTED
Cypress Semiconductor
CY
| $862K | ﹤0.01% |
101,183
+13,086
| +15% | +$137K |
|
1745
Healthcare Realty
HR
$6.58B
| $858K | ﹤0.01% |
35,000
+12,400
| +55% | +$306K |
|
1746
MGE Energy Inc
MGEE
$3.06B
| $855K | ﹤0.01% |
20,750
| – | – |
|
|
VSTO
1747
DELISTED
Vista Outdoor Inc.
VSTO
| $851K | ﹤0.01% |
19,150
+1,700
| +10% | +$77.6K |
|
1748
Brookfield
BN
$111B
| $846K | ﹤0.01% |
76,885
+2,563
| +3% | +$29.9K |
|
1749
AMN Healthcare
AMN
$1.34B
| $845K | ﹤0.01% |
28,157
+3,500
| +14% | +$116K |
|
|
QIWI
1750
DELISTED
QIWI PLC
QIWI
| $840K | ﹤0.01% |
+52,100
| New | +$1.28M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.